CTRI/2022/12/047926尚未招募4 期
Comparison of Levonorgestrel releasing intrauterine device vs. Gonadotropin-releasing hormone agonist (GnRH) in the treatment of adenomyosis in perimenopausal women: An open-label randomized trial - RCT
I0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Women in the perimenopausal (40-52 years) age group presenting to us with complaints of
- •heavy menstrual bleeding (with PBAC score more than or equal to 100) with or without pain and were
- •diagnosed with adenomyosis on USG.
排除标准
- •-Patient allergic to GnRH agonist (leuprolide).
- •-Patient on anticoagulants of any type like heparin, LMWH, warfarin, etc.
- •-Patients who are diagnosed with any other gynecological pathology other than
- •adenomyosis.
研究者
相似试验
尚未招募
不适用
other alternative medical treatment option of abnormal uterine bleedingCTRI/2020/05/025469AIIMS rishikesh
已完成
不适用
RCT comparing the levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation in women suffering from menorrhagiaHeavy menstrual bleeding1006447710013326MenorrhagiaNL-OMON41545Academisch Medisch Centrum266
已完成
不适用
Efficacy of Levonorgestrel-Releasing Intrauterine System for Treatment of Atypical Endometrial HyperplasiaAtypical endometrial hyperplasia, complexJPRN-UMIN000016528Hokkaido University Hospital10
尚未招募
不适用
The effect of hormonal releasing device put in uterus on its blood flow to know how it reduces menstrual bleedingCTRI/2022/02/040199All India Institute of Medical Sciences Nagpur
尚未招募
4 期
Comparison of effect of levonorgestrel intrauterine system vs tablet dienogest in adenomyosisCTRI/2020/05/025186AII india institute of medical Sciences Bhubaneswar